370 related articles for article (PubMed ID: 6954481)
1. Thiamin-responsive maple-syrup-urine disease: decreased affinity of the mutant branched-chain alpha-keto acid dehydrogenase for alpha-ketoisovalerate and thiamin pyrophosphate.
Chuang DT; Ku LS; Cox RP
Proc Natl Acad Sci U S A; 1982 May; 79(10):3300-4. PubMed ID: 6954481
[TBL] [Abstract][Full Text] [Related]
2. Biochemical basis of thiamin-responsive maple syrup urine disease.
Chuang DT; Ku LS; Cox RP
Trans Assoc Am Physicians; 1982; 95():196-204. PubMed ID: 7182976
[TBL] [Abstract][Full Text] [Related]
3. Activities of branched-chain 2-oxo acid dehydrogenase and its components in skin fibroblasts from normal and classical-maple-syrup-urine-disease subjects.
Chuang DT; Niu WL; Cox RP
Biochem J; 1981 Oct; 200(1):59-67. PubMed ID: 6895847
[TBL] [Abstract][Full Text] [Related]
4. A distinct variant of intermediate maple syrup urine disease.
Gonzalez-Rios MC; Chuang DT; Cox RP; Schmidt K; Knopf K; Packman S
Clin Genet; 1985 Feb; 27(2):153-9. PubMed ID: 3978850
[TBL] [Abstract][Full Text] [Related]
5. The role of thiamin in maple syrup urine disease.
Elsas LJ; Danner DJ
Ann N Y Acad Sci; 1982; 378():404-21. PubMed ID: 7044230
[No Abstract] [Full Text] [Related]
6. Detection of heterozygotes in maple-syrup-urine disease: measurements of branched-chain alpha-ketoacid dehydrogenase and its components in cell cultures.
Chuang DT; Ku LS; Kerr DS; Cox RP
Am J Hum Genet; 1982 May; 34(3):416-24. PubMed ID: 7081220
[TBL] [Abstract][Full Text] [Related]
7. Maple syrup urine disease: analysis of branched chain ketoacid decarboxylation in cultured fibroblasts.
Wendel U; Wentrup H; Rüdiger HW
Pediatr Res; 1975 Sep; 9(9):709-17. PubMed ID: 1202420
[TBL] [Abstract][Full Text] [Related]
8. Analysis of maple syrup urine disease in cell culture: use of substrates.
Schadewaldt P; Beck K; Wendel U
Clin Chim Acta; 1989 Sep; 184(1):47-56. PubMed ID: 2598467
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of maple syrup urine disease and stable correction by retroviral gene transfer.
Chuang DT; Davie JR; Wynn RM; Chuang JL; Koyata H; Cox RP
J Nutr; 1995 Jun; 125(6 Suppl):1766S-1772S. PubMed ID: 7782943
[TBL] [Abstract][Full Text] [Related]
10. Maple syrup urine disease: domain structure, mutations and exon skipping in the dihydrolipoyl transacylase (E2) component of the branched-chain alpha-keto acid dehydrogenase complex.
Chuang DT; Fisher CW; Lau KS; Griffin TA; Wynn RM; Cox RP
Mol Biol Med; 1991 Feb; 8(1):49-63. PubMed ID: 1943690
[TBL] [Abstract][Full Text] [Related]
11. Study on established lymphoid cells in maple syrup urine disease. Correlation with clinical heterogeneity.
Jinno Y; Akaboshi I; Katsuki T; Matsuda I
Hum Genet; 1984; 65(4):358-61. PubMed ID: 6693123
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the branched-chain alpha-ketoacid dehydrogenase and elucidation of a molecular basis for maple syrup urine disease.
Harris RA; Zhang B; Goodwin GW; Kuntz MJ; Shimomura Y; Rougraff P; Dexter P; Zhao Y; Gibson R; Crabb DW
Adv Enzyme Regul; 1990; 30():245-63. PubMed ID: 2403034
[TBL] [Abstract][Full Text] [Related]
13. Altered kinetic properties of the branched-chain alpha-keto acid dehydrogenase complex due to mutation of the beta-subunit of the branched-chain alpha-keto acid decarboxylase (E1) component in lymphoblastoid cells derived from patients with maple syrup urine disease.
Indo Y; Kitano A; Endo F; Akaboshi I; Matsuda I
J Clin Invest; 1987 Jul; 80(1):63-70. PubMed ID: 3597778
[TBL] [Abstract][Full Text] [Related]
14. Molecular phenotypes in cultured maple syrup urine disease cells. Complete E1 alpha cDNA sequence and mRNA and subunit contents of the human branched chain alpha-keto acid dehydrogenase complex.
Fisher CW; Chuang JL; Griffin TA; Lau KS; Cox RP; Chuang DT
J Biol Chem; 1989 Feb; 264(6):3448-53. PubMed ID: 2914958
[TBL] [Abstract][Full Text] [Related]
15. Primary human fibroblasts from a maple syrup urine disease patient undergo apoptosis following exposure to physiological concentrations of branched chain amino acids.
Jouvet P; Kozma M; Mehmet H
Ann N Y Acad Sci; 2000; 926():116-21. PubMed ID: 11193026
[TBL] [Abstract][Full Text] [Related]
16. Altered phosphorylation state of branched-chain 2-oxo acid dehydrogenase in a branched-chain acyltransferase deficient human fibroblast cell line.
Eisenstein RS; Hoganson G; Miller RH; Harper AE
J Inherit Metab Dis; 1991; 14(1):37-44. PubMed ID: 1861457
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity in maple syrup urine disease: aspects of cofactor requirement and complementation in cultured fibroblasts.
Singh S; Willers I; Goedde HW
Clin Genet; 1977 Apr; 11(4):277-84. PubMed ID: 192504
[TBL] [Abstract][Full Text] [Related]
18. Dietary thiamin level influences levels of its diphosphate form and thiamin-dependent enzymic activities of rat liver.
Blair PV; Kobayashi R; Edwards HM; Shay NF; Baker DH; Harris RA
J Nutr; 1999 Mar; 129(3):641-8. PubMed ID: 10082768
[TBL] [Abstract][Full Text] [Related]
19. Maple syrup urine disease in a Bedouin tribe: pre- and postnatal diagnosis.
Potashnik R; Carmi R; Sofer S; Bashan N; Abeliovich D
Isr J Med Sci; 1987 Aug; 23(8):886-9. PubMed ID: 3679791
[TBL] [Abstract][Full Text] [Related]
20. Stabilization of mammalian liver branched-chain alpha-ketoacid dehydrogenase by thiamin pyrophosphate.
Danner DJ; Lemmon SK; Elsas LJ
Arch Biochem Biophys; 1980 Jun; 202(1):23-8. PubMed ID: 7396533
[No Abstract] [Full Text] [Related]
[Next] [New Search]
